Chula is preparing to launch a CAR-T cell service to treat lymphoma later this year! June 19, 2024 Post Today follows the progress of CAR-T cell research, Chulalongkorn doctors...
World Immunotherapy Council (WIC)-Asian Chapter Pre-Conference Meeting June 2, 2024 The World Immunotherapy Council (WIC)-Asian Chapter Pre-Conference Meeting is set for June 28-29, 2024, in Shanghai, China. Co-hosted by...
The 2nd Thailand Hub of Talents in Cancer Immunotherapy International Conference Cancer Immunotherapy: From Promise to Precision – Delivering Personalized Treatments **Friday 12th July 2024** Faculty of Medicine Siriraj...
Exciting Breakthrough in CAR-T Cell Therapy Offers New Hope for Solid Tumor Treatment. In a groundbreaking study that could revolutionize cancer treatment, researchers have unveiled a new CAR-T cell...
In an exciting development in the field of cancer immunotherapy, researchers have engineered a new dual-target CAR T-cell therapy that simultaneously targets two key antigens, CD19 and CD20, in...
Unlock the Potential of Advanced Therapies: Join Our Crash Course! Are you ready to dive into the world of Advanced Therapeutic Medicinal Products (ATMPs)? Our two-day *Crash Course for...
Image by Erin_Hinterland/pixabay A groundbreaking study has delved into the potential interactions between cannabidiol (CBD) and CD19-chimeric antigen receptor (CAR) T cell therapy, a promising approach in cancer immunotherapy....
2023 Frontiers in Basic Immunology The Center for Cancer Research at the National Cancer Institute is hosting a two-day international symposium on September 27-28, 2023 entitled 2023 Frontiers in...
Thailand Hub of Talent for Cancer Immunotherapy International Conference: Portal to Global Collaboration for Next Generation Cell and Gene Therapy Development Date: 16-17th November 2023Venue: Bhumisiri Mangklanusorn Building, Faculty...
Image by Herney/pixabay In a notable advancement in cell engineering research, scientists have developed the first ligand-based, piggyBac-transfected anti-EGFR CAR-T cells, targeting non-small cell lung cancer (NSCLC). NSCLC often...
